Redmile Biopharma Investments I, L.P.
Redmile Biopharma Investments I, L.P. is a venture capital fund operated by Redmile Group and has approximately $74 million in assets. The current minimum investment for Redmile Biopharma Investments I, L.P. is $2000000. 44 percent of the fund is owned by fund of funds. Management owns 44 percent of the fund.
Redmile Biopharma Investments I, L.P. Overview
Fund Type: venture capital 
Private Fund ID: 805-3847972073
Fund Manager: Redmile Group (Crd# 143606)
Registered Location: Delaware, United States
Total Assets: $74 million
Minimum Investment: $2000000
Private Funds Managed by Redmile Group (10): Redmile Special Opportunities Fund Ltd, Redmile Capital Fund Lp , Redmile Capital Offshore Fund Erisa Ltd , Redmile Capital Offshore Fund Ii Ltd , Redmile Capital Offshore Fund Ltd , Redmile Long Only Master Fund Lp , Redmile Biopharma Investments I Lp , Redmile Private Investments I Affiliates Lp , Redmile Private Investments I Lp , Redmile Private Investments Ii Lp
Redmile Biopharma Investments I, L.P. Details
Subadviser: No
Other Investment Advisers: No
Solicited: No
Rely on Reg D Exemption: Yes
Audited: Yes
Master Fund: Yes
Feeder Fund: No
GAAP: Yes
Beneficial Owners: 22
Management Ownership: 44%
Fund of Fund Ownership: 24%
Non-US Ownership: 41%
Auditor(s): KPMG LLP
Broker-Dealer(s):
Custodian(s): Morgan Stanley & Co. LLC, ,
Administrator(s): Greenough Consulting Group
Redmile Biopharma Investments I, L.P. Charts and Graphs
Total AUM: $74 million
Rank: 12162 out of 30967 registered private funds
Minimum Investment: $2000000
Rank: 6953 out of 30967 registered private funds
Management Ownership: 44%
Rank: 4037 out of 30967 registered private funds
Go back to private fund search
